DOCSLIB.ORG

PTH Decreases in Vitro Human Cartilage Regeneration Without Affecting Hypertrophic

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
PTH Decreases in Vitro Human Cartilage Regeneration Without Affecting Hypertrophic bioRxiv preprint doi: https://doi.org/10.1101/560771; this version posted February 26, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 PTH decreases in vitro human cartilage regeneration without affecting hypertrophic 2 differentiation 3 4 Marijn Rutgers1, Frances Bach2, Luciënne Vonk1, Mattie van Rijen1, Vanessa Akrum1, 5 Antonette van Boxtel1, Wouter Dhert1,2, Laura Creemers1 6 7 1 Department of Orthopedics, University Medical Center Utrecht, Utrecht, the Netherlands 8 2 Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, 9 Utrecht University, Utrecht, the Netherlands 10 11 Address for correspondence 12 Dr. F.C.Bach 13 Utrecht University, Faculty of Veterinary Medicine, 14 Yalelaan 104, 3584 CM Utrecht, the Netherlands 15 [email protected], +31302537563 16 1 bioRxiv preprint doi: https://doi.org/10.1101/560771; this version posted February 26, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 18 Abstract 19 Regenerated cartilage formed after Autologous Chondrocyte Implantation may be of 20 suboptimal quality due to postulated hypertrophic changes. Parathyroid hormone-related 21 peptide, containing the parathyroid hormone sequence (PTHrP 1-34), enhances cartilage 22 growth during development and inhibits hypertrophic differentiation of mesenchymal stromal 23 cells (MSCs) and growth plate chondrocytes. This study aims to determine whether human 24 articular chondrocytes respond correspondingly. Healthy human articular cartilage-derived 25 chondrocytes (n=6 donors) were cultured on type II collagen-coated transwells with/without 26 0.1 or 1.0 μM PTH from day 0, 9, or 21 until the end of culture (day 28). Extracellular matrix 27 production, (pre)hypertrophy and PTH signaling were assessed by RT-qPCR and/or 28 immunohistochemistry for collagen type I, II, X, RUNX2, MMP13, PTHR1 and IHH and by 29 determining glycosaminoglycan production and DNA content. The Bern score assessed 30 cartilage quality by histology. Regardless of the concentration and initiation of 31 supplementation, PTH treatment significantly decreased DNA and glycosaminoglycan 32 content and reduced the Bern score compared with controls. Type I collagen deposition was 33 increased, whereas PTHR1 expression and type II collagen deposition were decreased by 34 PTH supplementation. Expression of the (pre)hypertrophic markers MMP13, RUNX2, IHH 35 and type X collagen were not affected by PTH. In conclusion, PTH supplementation to 36 healthy human articular chondrocytes did not affect hypertrophic differentiation, but 37 negatively influenced cartilage quality, the tissues’ extracellular matrix and cell content. 38 Although PTH may be an effective inhibitor of hypertrophic differentiation in MSC-based 39 cartilage repair, care may be warranted in applying accessory PTH treatment due to its effects 40 on articular chondrocytes. 41 42 2 bioRxiv preprint doi: https://doi.org/10.1101/560771; this version posted February 26, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 43 Introduction 44 Autologous chondrocyte implantation (ACI) is an effective treatment in patients with 45 medium-sized cartilage defects (1). Chondrocytes isolated from healthy non weight-bearing 46 cartilage and re-transplanted after in vitro expansion ideally fill the void with hyaline 47 neocartilage (2). Variable results have, however, been found regarding the obtained cartilage 48 quality, with fibrous or even hypertrophically differentiated tissue instead of healthy cartilage 49 (3). Similarly, MSC-based regeneration either as part of microfracture procedures or as 50 exogenous cell source has been shown to result in hypertrophic differentiation (4). A possible 51 tool to prevent this unfavorable differentiation pathway may be the co-administration of 52 parathyroid hormone related-peptide (PTHrP). 53 PTHrP plays an important role in early development and limb growth (5) and is crucial in 54 maintaining the chondrocytic phenotype in native cartilage. In the growth plate, a highly 55 organized cartilage structure that enables longitudinal bone growth, PTHrP maintains 56 chondrocytes in a proliferating state and prevents hypertrophic differentiation and bone 57 formation (6). Parathyroid hormone (PTH) is assumed to have similar effects as PTHrP (7,8), 58 as they share their N-terminus and receptor (PTHR1) (9,10). Both PTH and PTHrP can 59 enhance cartilage formation by stimulating the expression of SRY-box 9 (6) (SOX9, 60 transcription factor required for chondrocyte differentiation and cartilage formation (11)) and 61 by increasing cell proliferation through induction of cyclin D1 (CCND1) (12). PTHrP/PTH 62 have been demonstrated to stimulate chondrogenic differentiation of mesenchymal stromal 63 cells (MSCs) and to prevent hypertrophic differentiation of MSCs (13-17) and growth plate 64 chondrocytes (18,19) in vitro. Lastly, in rabbit osteochondral defects, intra-articular PTH 65 administration stimulated tissue regeneration in vivo (20,21). In contrast to osteochondral 66 defect healing, ACI is based on chondrocyte implantation, either or not supplemented with 67 MSCs (22). Although expanding chondrocytes have stem cell-like properties (23), 3 bioRxiv preprint doi: https://doi.org/10.1101/560771; this version posted February 26, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 68 multilineage (especially osteogenic and adipogenic) differentiation efficacy is very low 69 compared with MSCs, which may indicate that a chondroid precursor, but not a multipotent 70 mesenchymal cell type is present in expanding chondrocytes (24). 71 As yet, it is unknown whether PTH may have similar effects on articular chondrocyte- 72 mediated regeneration in terms of inhibition of hypertrophy and stimulation of regeneration. 73 Therefore, in order to define whether PTH holds promise as an additive treatment strategy to 74 current challenges faced by ACI, this study determined the effects of PTH on expanded 75 human articular chondrocytes in an in vitro model of cartilage regeneration. 76 77 Materials and Methods 78 Human chondrocytes 79 Healthy human femoral knee cartilage of three male and three female donors (mean age 68, 80 range 47-83 years) was obtained post-mortem. Only macroscopically intact (Collins grade 0-1 81 (25)) cartilage was used (four samples grade 0, two samples grade 1). Collection of all patient 82 material was done according to the Medical Ethical regulations of the University Medical 83 Center Utrecht and according to the guideline ‘good use of redundant tissue for clinical 84 research’ constructed by the Dutch Federation of Medical Research Societies on collection of 85 redundant tissue for research (www.fedara.org). This study does not meet the definition of 86 human subjects research or require informed consent. Anonymous use of redundant tissue for 87 research purposes is part of the standard treatment agreement with patients in our hospital 88 (26). 89 90 Chondrocyte isolation and expansion 91 Cartilage was digested overnight in Dulbecco’s modified Eagle Medium (DMEM; 42430, 92 Invitrogen) containing 0.1% w/v collagenase type II (CLS2, Worthington), 1% v/v 4 bioRxiv preprint doi: https://doi.org/10.1101/560771; this version posted February 26, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 93 penicillin/streptomycin (P/S; 15140, Invitrogen). Isolated chondrocytes were washed in PBS 94 and expanded at 5000 cells/cm2 in DMEM containing 1% P/S, 10% v/v fetal bovine serum 95 (DE14-801F, Lonza), 10 ng/mL FGF (223-FB, R&D Systems). At 80% confluency, cells 96 were trypsinized and passaged. Passage two cells were used for redifferentiation culture or 97 snap-frozen for RNA analysis. 98 99 Redifferentiation culture 100 Since more recent ACI versions are based on collagen carriers (27), the chondrocytes were 101 cultured on collagen type II-coated membranes in a 24-wells transwell system as described 102 previously (28). Passage two chondrocytes were seeded on inserts (PICM01250, Millipore) 103 with a hydrophilic poly-tetrafluoroethylene (PTFE) membrane at 1.6 x106 cells/cm2 in 104 DMEM with 2% w/v ITSx (51500, Invitrogen), 2% w/v ascorbic acid (A8960, Sigma- 105 Aldrich), 2% w/v human serum albumin (HS-440, Seracare Life Sciences), 100 units/mL 106 penicillin, 100 μg/mL streptomycin, and 10 ng/mL TGF-2 (302-B2, R&D Systems). Before 107 culture, the membranes had been coated with 0.125 mg/mL type II collagen (C9301, Sigma- 108 Aldrich) in 0.1 M acetic acid. After thorough rinsing, efficient coating was verified by 109 immunohistochemistry (29). To mimic the different phases of maturation, PTH was supplied 110 at different time points in two different concentrations: 0.1 or 1.0 μM PTH (based on 111 Kafienah et al. (2007) (13)) was added every media change (three times a week) from days 0 112 (n=4), 9 (n=6) or 21 (n=6) onwards, whereas the controls (n=6) did not receive PTH. After 28 113 days, the tissues were fixed in 10% w/v neutral buffered formalin (for histological analysis) 114 or snap-frozen and stored at -20 ºC (glycosaminoglycan (GAG) and DNA content analysis) or 115 -80 ºC (for RNA analysis). 116 117 Gene expression analysis 5 bioRxiv preprint doi: https://doi.org/10.1101/560771; this version posted February 26, 2019.
Load more

Recommended publications
  • Normal Osteoid Tissue
    J Clin Pathol: first published as 10.1136/jcp.25.3.229 on 1 March 1972. Downloaded from J. clin. Path., 1972, 25, 229-232 Normal osteoid tissue VINITA RAINA From the Department of Morbid Anatomy, Institute of Orthopaedics, London SYNOPSIS The results of a histological study of normal osteoid tissue in man, the monkey, the dog, and the rat, using thin microtome sections of plastic-embedded undecalcified bone, are described. Osteoid tissue covers the entire bone surface, except for areas of active resorption, although the thickness of the layer of osteoid tissue varies at different sites and in different species of animals. The histological features of osteoid tissue, apart from its amount, are the same in the different species studied. Distinct bands or zones are recognizable in some layers of osteoid tissue, particularly those of greatest thickness, and their significance is discussed. Some of the histological features of the calcification front are described. Osteoid tissue is defined as unmineralized bone The concept of osteoid tissue as a necessary stage tissue. Its presence in large amounts is a distinctive in bone formation was not accepted by all workers. histological feature of osteomalacia (Sissons and von Recklinghausen (1910) believed that the Aga, 1970), but it is also present in smaller quantities presence of osteoid tissue was the result of with- copyright. in normal conditions and is then usually regarded as drawal of bone mineral from calcified bone ('hali- representing an initial stage in the formation of steresis'). This concept, though not generally calcified bone tissue. accepted, has been revived in recent years in con- It was Virchow, in 1851, on the basis of a histo- nexion with the removal of bone mineral from the logical study of human bone specimens partially or immediate vicinity of osteocytes in calcified bone completely decalcified in hydrochloric acid, who (Belanger, Robichon, Migicovsky, Copp, and first put forward the concept that mineralization Vincent, 1963).
    [Show full text]
  • Osteocyte Dysfunction Promotes Osteoarthritis Through MMP13-Dependent Suppression of Subchondral Bone Homeostasis
    Bone Research www.nature.com/boneres ARTICLE OPEN Osteocyte dysfunction promotes osteoarthritis through MMP13-dependent suppression of subchondral bone homeostasis Courtney M. Mazur1,2, Jonathon J. Woo 1, Cristal S. Yee1, Aaron J. Fields 1, Claire Acevedo1,3, Karsyn N. Bailey1,2, Serra Kaya1, Tristan W. Fowler1, Jeffrey C. Lotz1,2, Alexis Dang1,4, Alfred C. Kuo1,4, Thomas P. Vail1 and Tamara Alliston1,2 Osteoarthritis (OA), long considered a primary disorder of articular cartilage, is commonly associated with subchondral bone sclerosis. However, the cellular mechanisms responsible for changes to subchondral bone in OA, and the extent to which these changes are drivers of or a secondary reaction to cartilage degeneration, remain unclear. In knee joints from human patients with end-stage OA, we found evidence of profound defects in osteocyte function. Suppression of osteocyte perilacunar/canalicular remodeling (PLR) was most severe in the medial compartment of OA subchondral bone, with lower protease expression, diminished canalicular networks, and disorganized and hypermineralized extracellular matrix. As a step toward evaluating the causality of PLR suppression in OA, we ablated the PLR enzyme MMP13 in osteocytes while leaving chondrocytic MMP13 intact, using Cre recombinase driven by the 9.6-kb DMP1 promoter. Not only did osteocytic MMP13 deficiency suppress PLR in cortical and subchondral bone, but it also compromised cartilage. Even in the absence of injury, osteocytic MMP13 deficiency was sufficient to reduce cartilage proteoglycan content, change chondrocyte production of collagen II, aggrecan, and MMP13, and increase the 1234567890();,: incidence of cartilage lesions, consistent with early OA. Thus, in humans and mice, defects in PLR coincide with cartilage defects.
    [Show full text]
  • The Healing Pattern of Osteoid Osteomas on Computed Tomography and Magnetic Resonance Imaging After Thermocoagulation
    Skeletal Radiol (2007) 36:813–821 DOI 10.1007/s00256-007-0319-1 SCIENTIFIC ARTICLE The healing pattern of osteoid osteomas on computed tomography and magnetic resonance imaging after thermocoagulation Geert M. Vanderschueren & Antoni H. M. Taminiau & Wim R. Obermann & Annette A. van den Berg-Huysmans & Johan L. Bloem & Arian R. van Erkel Received: 16 December 2006 /Revised: 17 February 2007 /Accepted: 23 March 2007 / Published online: 11 May 2007 # ISS 2007 Abstract unsuccessful in 27% (23/86) of patients followed by CT. Objective To compare the healing pattern of osteoid Thermocoagulation was successful in 72% (13/18) of patients osteomas on computed tomography (CT) and magnetic followed by MRI. After treatment, the healing of the nidus on resonance imaging (MRI) after successful and unsuccessful CT was evaluated using different healing patterns (complete thermocoagulation. ossification, minimal nidus rest, decreased size, unchanged Materials and methods Eighty-six patients were examined size or thermonecrosis). On MRI the presence of reactive by CT and 18 patients by dynamic gadolinium-enhanced MRI changes (joint effusion, “oedema-like” changes of bone before and after thermocoagulation for osteoid osteoma. marrow and soft tissue oedema) and the delay time (between Thermocoagulation was successful in 73% (63/86) and arterial and nidus enhancement) were assessed and compared before and after thermocoagulation. G. M. Vanderschueren (*) Results Complete ossification or a minimal nidus rest was Department of Diagnostic Radiology, observed on CT in 58% (16/28) of treatment successes University Hospital of Ghent, De Pintelaan 185, (with > 12 months follow-up), but not in treatment Ghent 9000, Belgium failures. “Oedema-like” changes of bone marrow and/or e-mail: [email protected] soft tissue oedema were seen on MR in all patients before thermocoagulation and in all treatment failures.
    [Show full text]
  • Osteocyte Differentiation and the Formation of an Interconnected Cellular Network in Vitro
    EuropeanMJ Mc Garrigle Cells and et alMaterials. Vol. 31 2016 (pages 323-340) DOI: 10.22203/eCM.v031a21Formation of an interconnected osteocyte ISSN 1473-2262 network OSTEOCYTE DIFFERENTIATION AND THE FORMATION OF AN INTERCONNECTED CELLULAR NETWORK IN VITRO M.J. Mc Garrigle1, C.A. Mullen1, M.G. Haugh1, M.C. Voisin1 and L.M. McNamara1* 1 Centre for Biomechanics Research (BMEC), Biomedical Engineering, College of Engineering and Informatics, National University of Ireland, Galway Abstract Introduction Extracellular matrix (ECM) stiffness and cell density can In bone, osteocyte cells form a complex three-dimensional regulate osteoblast differentiation in two dimensional (3D) communication network that plays a vital role in environments. However, it is not yet known how maintaining bone health by monitoring physical cues osteoblast-osteocyte differentiation is regulated within a arising during load-bearing activity and directing the 3D ECM environment, akin to that existing in vivo. In this activity of osteoblasts and osteoclasts to initiate bone study we test the hypothesis that osteocyte differentiation is formation and resorption (Burger and Klein-Nulend, 1999). regulated by a 3D cell environment, ECM stiffness and cell Osteocytes are formed when cuboidal-like osteoblasts density. We encapsulated MC3T3-E1 pre-osteoblastic cells become embedded within soft secreted osteoid and start to at varied cell densities (0.25, 1 and 2 × 106 cells/mL) within change morphologically to a dendritic shape characteristic microbial transglutaminase (mtgase) gelatin hydrogels of an osteocyte. This transition is accompanied by a loss of low (0.58 kPa) and high (1.47 kPa) matrix stiffnesses. of cell volume (reduced organelle content) (Knothe Tate Cellular morphology was characterised from phalloidin- et al., 2004; Palumbo et al., 2004) and an increase in the FITC and 4’,6-diamidino-2-phenylindole (DAPI) dilactate formation and elongation of thin cytoplasmic projections staining.
    [Show full text]
  • The Challenge of Articular Cartilage Repair
    Doctoral Program of Clinical Research Faculty of Medicine University of Helsinki Finland THE CHALLENGE OF ARTICULAR CARTILAGE REPAIR STUDIES ON CARTILAGE REPAIR IN ANIMAL MODELS AND IN CELL CULTURE Eve Salonius ACADEMIC DISSERTATION To be presented, with the permission of the Faculty of Medicine of the University of Helsinki, for public examination in lecture room PIII, Porthania, Yliopistonkatu 3, on Friday the 22nd of November, 2019 at 12 o’clock. Helsinki 2019 Supervisors: Professor Ilkka Kiviranta, M.D., Ph.D. Department of Orthopaedics and Traumatology Clinicum Faculty of Medicine University of Helsinki Finland Virpi Muhonen, Ph.D. Department of Orthopaedics and Traumatology Clinicum Faculty of Medicine University of Helsinki Finland Reviewers: Professor Heimo Ylänen, Ph.D. Department of Electronics and Communications Engineering Tampere University of Technology Finland Adjunct Professor Petri Virolainen, M.D., Ph.D. Department of Orthopaedics and Traumatology University of Turku Finland Opponent: Professor Leif Dahlberg, M.D., Ph.D. Department of Orthopaedics Lund University Sweden The Faculty of Medicine uses the Urkund system (plagiarism recognition) to examine all doctoral dissertations © Eve Salonius 2019 ISBN 978-951-51-5613-6 (paperback) ISBN 978-951-51-5614-3 (PDF) Unigrafia Helsinki 2019 ABSTRACT Articular cartilage is highly specialized connective tissue that covers the ends of bones in joints. Damage to articulating joint surface causes pain and loss of joint function. The prevalence of cartilage defects is expected to increase, and if untreated, they may lead to premature osteoarthritis, the world’s leading joint disease. Early intervention may cease this process. The first-line treatment of non-surgical management of articular cartilage defects is physiotherapy and pain medication to alleviate symptoms.
    [Show full text]
  • The Epiphyseal Plate: Physiology, Anatomy, and Trauma*
    3 CE CREDITS CE Article The Epiphyseal Plate: Physiology, Anatomy, and Trauma* ❯❯ Dirsko J. F. von Pfeil, Abstract: This article reviews the development of long bones, the microanatomy and physiology Dr.med.vet, DVM, DACVS, of the growth plate, the closure times and contribution of different growth plates to overall growth, DECVS and the effect of, and prognosis for, traumatic injuries to the growth plate. Details on surgical Veterinary Specialists of Alaska Anchorage, Alaska treatment of growth plate fractures are beyond the scope of this article. ❯❯ Charles E. DeCamp, DVM, MS, DACVS athologic conditions affecting epi­ foramen. Growth factors and multipotent Michigan State University physeal (growth) plates in imma­ stem cells support the formation of neo­ ture animals may result in severe natal bone consisting of a central marrow P 2 orthopedic problems such as limb short­ cavity surrounded by a thin periosteum. ening, angular limb deformity, or joint The epiphysis is a secondary ossifica­ incongruity. Understanding growth plate tion center in the hyaline cartilage forming anatomy and physiology enables practic­ the joint surfaces at the proximal and distal At a Glance ing veterinarians to provide a prognosis ends of the bones. Secondary ossification Bone Formation and assess indications for surgery. Injured centers can appear in the fetus as early Page E1 animals should be closely observed dur­ as 28 days after conception1 (TABLE 1). Anatomy of the Growth ing the period of rapid growth. Growth of the epiphysis arises from two Plate areas: (1) the vascular reserve zone car­ Page E2 Bone Formation tilage, which is responsible for growth of Physiology of the Growth Bone is formed by transformation of con­ the epiphysis toward the joint, and (2) the Plate nective tissue (intramembranous ossifica­ epiphyseal plate, which is responsible for Page E4 tion) and replacement of a cartilaginous growth in bone length.3 The epiphyseal 1 Growth Plate Closure model (endochondral ossification).
    [Show full text]
  • Cartilage & Bone
    Cartilage & bone Red: important. Black: in male|female slides. Gray: notes|extra. Editing File ➢ OBJECTIVES • describe the microscopic structure, distribution and growth of the different types of Cartilage • describe the microscopic structure, distribution and growth of the different types of Bone Histology team 437 | MSK block | Lecture one ➢ REMEMBER from last block (connective tissue lecture) Components of connective tissue Fibers Cells Collagenous, Matrix difference elastic & the intercellular substance, in which types reticular cells and fibers are embedded. Rigid (rubbery, Hard (solid) Fluid (liquid) Soft firm) “Cartilage” “Bone” “Blood” “C.T Proper” Histology team 437 | MSK block | Lecture one CARTILAGE “Chondro- = relating to cartilage” BONE “Osteo- = relating to bone” o Its specialized type of connective tissue with a rigid o Its specialized type of connective tissue with a hard matrix (ﻻ يكسر بسهولة) matrix o Its usually nonvascular (avascular = lack of blood o Types: vessels) 1) Compact bone 2) Spongy bone o Its poor nerve supply o Components: 1) Bone cells: o All cartilage contain collagen fiber type II • Osteogenic cells • Osteoblasts o Types: • Osteocytes 1) Hyaline cartilage (main type) • Osteoclasts 2) Elastic cartilage 2) Bone Matrix (calcified osteoid tissue): 3) Fibrocartilage • hard because it is calcified (Calcium salts) • It contains collagen fibers type I • It forms bone lamellae and trabeculae 3) Periosteum 4) Endosteum o Functions: 1) body support 2) protection of vital organs as brain & bone marrow 3) calcium
    [Show full text]
  • Nomina Histologica Veterinaria, First Edition
    NOMINA HISTOLOGICA VETERINARIA Submitted by the International Committee on Veterinary Histological Nomenclature (ICVHN) to the World Association of Veterinary Anatomists Published on the website of the World Association of Veterinary Anatomists www.wava-amav.org 2017 CONTENTS Introduction i Principles of term construction in N.H.V. iii Cytologia – Cytology 1 Textus epithelialis – Epithelial tissue 10 Textus connectivus – Connective tissue 13 Sanguis et Lympha – Blood and Lymph 17 Textus muscularis – Muscle tissue 19 Textus nervosus – Nerve tissue 20 Splanchnologia – Viscera 23 Systema digestorium – Digestive system 24 Systema respiratorium – Respiratory system 32 Systema urinarium – Urinary system 35 Organa genitalia masculina – Male genital system 38 Organa genitalia feminina – Female genital system 42 Systema endocrinum – Endocrine system 45 Systema cardiovasculare et lymphaticum [Angiologia] – Cardiovascular and lymphatic system 47 Systema nervosum – Nervous system 52 Receptores sensorii et Organa sensuum – Sensory receptors and Sense organs 58 Integumentum – Integument 64 INTRODUCTION The preparations leading to the publication of the present first edition of the Nomina Histologica Veterinaria has a long history spanning more than 50 years. Under the auspices of the World Association of Veterinary Anatomists (W.A.V.A.), the International Committee on Veterinary Anatomical Nomenclature (I.C.V.A.N.) appointed in Giessen, 1965, a Subcommittee on Histology and Embryology which started a working relation with the Subcommittee on Histology of the former International Anatomical Nomenclature Committee. In Mexico City, 1971, this Subcommittee presented a document entitled Nomina Histologica Veterinaria: A Working Draft as a basis for the continued work of the newly-appointed Subcommittee on Histological Nomenclature. This resulted in the editing of the Nomina Histologica Veterinaria: A Working Draft II (Toulouse, 1974), followed by preparations for publication of a Nomina Histologica Veterinaria.
    [Show full text]
  • Biology of Bone Repair
    Biology of Bone Repair J. Scott Broderick, MD Original Author: Timothy McHenry, MD; March 2004 New Author: J. Scott Broderick, MD; Revised November 2005 Types of Bone • Lamellar Bone – Collagen fibers arranged in parallel layers – Normal adult bone • Woven Bone (non-lamellar) – Randomly oriented collagen fibers – In adults, seen at sites of fracture healing, tendon or ligament attachment and in pathological conditions Lamellar Bone • Cortical bone – Comprised of osteons (Haversian systems) – Osteons communicate with medullary cavity by Volkmann’s canals Picture courtesy Gwen Childs, PhD. Haversian System osteocyte osteon Picture courtesy Gwen Childs, PhD. Haversian Volkmann’s canal canal Lamellar Bone • Cancellous bone (trabecular or spongy bone) – Bony struts (trabeculae) that are oriented in direction of the greatest stress Woven Bone • Coarse with random orientation • Weaker than lamellar bone • Normally remodeled to lamellar bone Figure from Rockwood and Green’s: Fractures in Adults, 4th ed Bone Composition • Cells – Osteocytes – Osteoblasts – Osteoclasts • Extracellular Matrix – Organic (35%) • Collagen (type I) 90% • Osteocalcin, osteonectin, proteoglycans, glycosaminoglycans, lipids (ground substance) – Inorganic (65%) • Primarily hydroxyapatite Ca5(PO4)3(OH)2 Osteoblasts • Derived from mesenchymal stem cells • Line the surface of the bone and produce osteoid • Immediate precursor is fibroblast-like Picture courtesy Gwen Childs, PhD. preosteoblasts Osteocytes • Osteoblasts surrounded by bone matrix – trapped in lacunae • Function
    [Show full text]
  • The Osteocyte: from “Prisoner” to “Orchestrator”
    Journal of Functional Morphology and Kinesiology Review The Osteocyte: From “Prisoner” to “Orchestrator” Carla Palumbo * and Marzia Ferretti Section of Human Morphology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy; [email protected] * Correspondence: [email protected] Abstract: Osteocytes are the most abundant bone cells, entrapped inside the mineralized bone matrix. They derive from osteoblasts through a complex series of morpho-functional modifications; such modifications not only concern the cell shape (from prismatic to dendritic) and location (along the vascular bone surfaces or enclosed inside the lacuno-canalicular cavities, respectively) but also their role in bone processes (secretion/mineralization of preosseous matrix and/or regulation of bone remodeling). Osteocytes are connected with each other by means of different types of junctions, among which the gap junctions enable osteocytes inside the matrix to act in a neuronal-like manner, as a functional syncytium together with the cells placed on the vascular bone surfaces (osteoblasts or bone lining cells), the stromal cells and the endothelial cells, i.e., the bone basic cellular system (BBCS). Within the BBCS, osteocytes can communicate in two ways: by means of volume transmission and wiring transmission, depending on the type of signals (metabolic or mechanical, respectively) received and/or to be forwarded. The capability of osteocytes in maintaining skeletal and mineral homeostasis is due to the fact that it acts as a mechano-sensor, able to transduce mechanical strains into biological signals and to trigger/modulate the bone remodeling, also because of the relevant role of sclerostin secreted by osteocytes, thus regulating different bone cell signaling pathways.
    [Show full text]
  • Insulin-Like Growth Factors: Actions on the Skeleton
    61 1 Journal of Molecular S Yakar et al. IGFs and bone 61:1 T115–T137 Endocrinology THEMATIC REVIEW 40 YEARS OF IGF1 Insulin-like growth factors: actions on the skeleton Shoshana Yakar1, Haim Werner2 and Clifford J Rosen3 1David B. Kriser Dental Center, Department of Basic Science and Craniofacial Biology, New York University College of Dentistry, New York, New York, USA 2Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel 3Maine Medical Center Research Institute, Scarborough, Maine, USA Correspondence should be addressed to S Yakar: [email protected] This paper forms part of a special section on 40 years of IGF1. The guest editors for this section were Derek LeRoith and Emily Gallagher. Abstract The discovery of the growth hormone (GH)-mediated somatic factors (somatomedins), Key Words insulin-like growth factor (IGF)-I and -II, has elicited an enormous interest primarily f insulin-like among endocrinologists who study growth and metabolism. The advancement of f osteoblast molecular endocrinology over the past four decades enables investigators to re-examine f osteoclast and refine the established somatomedin hypothesis. Specifically, gene deletions, f osteocyte transgene overexpression or more recently, cell-specific gene-ablations, have enabled f chondrocyte investigators to study the effects of the Igf1 and Igf2 genes in temporal and spatial manners. The GH/IGF axis, acting in an endocrine and autocrine/paracrine fashion, is the major axis controlling skeletal growth. Studies in rodents have clearly shown that IGFs regulate bone length of the appendicular skeleton evidenced by changes in chondrocytes of the proliferative and hypertrophic zones of the growth plate.
    [Show full text]
  • Cellular Processes by Which Osteoblasts and Osteocytes Control Bone Mineral Deposition and Maturation Revealed by Stage-Specific Ephrinb2 Knockdown
    Current Osteoporosis Reports (2019) 17:270–280 https://doi.org/10.1007/s11914-019-00524-y SKELETAL BIOLOGY AND REGULATION (M FORWOOD AND A ROBLING, SECTION EDITORS) Cellular Processes by Which Osteoblasts and Osteocytes Control Bone Mineral Deposition and Maturation Revealed by Stage-Specific EphrinB2 Knockdown Martha Blank1 & Natalie A. Sims1 Published online: 10 August 2019 # Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract Purpose of Review We outline the diverse processes contributing to bone mineralization and bone matrix maturation by describ- ing two mouse models with bone strength defects caused by restricted deletion of the receptor tyrosine kinase ligand EphrinB2. Recent Findings Stage-specific EphrinB2 deletion differs in its effects on skeletal strength. Early-stage deletion in osteoblasts leads to osteoblast apoptosis, delayed initiation of mineralization, and increased bone flexibility. Deletion later in the lineage targeted to osteocytes leads to a brittle bone phenotype and increased osteocyte autophagy. In these latter mice, although mineralization is initiated normally, all processes involved in matrix maturation, including mineral accrual, carbonate substitu- tion, and collagen compaction, progress more rapidly. Summary Osteoblasts and osteocytes control the many processes involved in bone mineralization; defining the contributing signaling activities may lead to new ways to understand and treat human skeletal fragilities. Keywords Biomineralization . Mineralization . Bone matrix . Osteocyte . EphrinB2 . Osteoblast Introduction because of changes in mineral structure brought about by in- corporation of fluoride into the apatite structure [1]. This review Bone strength is determined both by its mass and its mechanical will focus on recent advances describing the processes by competence governed by relative collagen and mineral levels in which bone matrix matures and the stages in the osteoblast the bone matrix.
    [Show full text]